Hydrogels based on interpenetrating network of chitosan and polyvinyl pyrrolidone for pH-sensitive delivery of repaglinide

Current Drug Discovery Technologies

Volumn 8, Issue 2, 2011, Pages 126-135

  Vaghani, Subhash S ^a   Patel, Madhabhai M ^b  

^a Jodhpur National University   (India)

^b Kalol Institute of Pharmacy   (India)

Author keywords

Chitosan; Controlled releaseRepaglinide.; Hydrogel; Polyvinyl pyrrolidone; Semi IPN

Indexed keywords

CHITOSAN; GLUTARALDEHYDE; POLYMER; POVIDONE; REPAGLINIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CROSS LINKING; DIFFUSION; DRUG SOLUBILITY; HYDROGEL; MUCOADHESION; NONHUMAN; PH; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; SYNTHESIS; WETTABILITY;

ADHESIVENESS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMATES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CROSS-LINKING REAGENTS; CRYSTALLOGRAPHY, X-RAY; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; GASTRIC JUICE; GLUTARAL; HYDROGELS; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; PIPERIDINES; POVIDONE; POWDER DIFFRACTION; RATS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; WETTABILITY;

EID: 79956084994     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016311795563848     Document Type: Article

References (53)

1. De-Rossi D, Kajiwara K, Osada Y, Yamauchi A. Polymer gels. Plenum: New York 1991.
2. Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 2010; 62: 83-99.
3. Dumitriu S, Vidal P, Chornet E. Polysaccharides in medical application. Marcel Dekker: New York 1996.
4. Cascone MG, Barbani N, Cristallini C, Giusti P, Ciardelli G, Lazzer L. Bioartificial polymeric materials based on polysaccharides. J Biomat Sci-Polym E 2001; 12(3): 267-81. (Pubitemid 32577106)
5. Crescenzi V, Paradossi G, Desideri P, Dentini M, Cavalieri F, Amici E, Lisi R. New hydrogels based on carbohydrate synthetic polymernetworks. Polym Gels Netw 1997; 5: 225-39. (Pubitemid 127451755)
6. Muzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, Gazzanelli G, Vasi V. Biological activity of chitosan: ultra-structural study. Biomaterials 1988; 9(3): 247-52.
7. Majeti NV, Kumar R. A review of chitin and chitosan. React Funct Polym 2000; 46: 1-27.
8. Inouye K, Machida Y, Sannan T, Nagai T. Buoyant sustained release tablets based on chitosan. Drug Design Deliv 1988; 2(3): 165-75. (Pubitemid 18039210)
9. Chandy T, Sharma CP. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. Biomterials 1992; 13(13): 949-52.
10. Chandy T, Sharma CP. Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials 1993; 14(12): 939-44. (Pubitemid 23305990)
11. Singer EJ, Pittz EP. In: Surfactants in cosmetics; Rieger MM, Ed. Marcel Dekker: New York 1985.
12. Zhao L, Xu L, Mitomo H, Yoshii F. Synthesis of pH-sensitive PVP/CM-chitosan hydrogels with improved surface property by irradiation. Carbohydr Polym 2006; 64(3): 473-80.
13. Hong Y, Chirila T, Vijaysekaran S, Shen W, Lou X, Dalton P. Biodegradation in vitro and retention in the rabbit eye of the crossinked poly(1-vinyl-2-pyrrolidone) hydrogels as a vitreous substitute. J Biomed Mater Res 1998; 39: 650-9. (Pubitemid 28079730)
14. Huglin MB, Zakaria MB. Swelling properties of copolymeric hydrogels prepared by gamma irradiation. J Appl Polym Sci 1986; 31(2): 457-75.
15. Siegel RA, Falamarzian M, Firestone BA, Moxley BC. pH controlled release from hydrophobic/polyelectrolyte copolymer hydrogel. J Control Release 1988; 8: 179-82. (Pubitemid 19010924)
16. Risbud MV, Hardikar AA, Bhat SV, Bhonde RR. pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J Control Release 2000; 68: 23-30. (Pubitemid 30407059)
17. Remunan-Lopez C, Lorenzo-Lamosa ML, Vila-Jato JL, Alonso MJ. Development of new chitosan-cellulose multicore microcapsules for controlled drug delivery. Eur J Pharm Biopharm 1988; 45(1): 49-56.
18. Lhommeau C, Toillon S, Pith T, Kessler L, Jesser C, Pinget M. Polyamide 4,6 membranes for the encapsulation of Langerhans islets: preparation, physico-chemical properties and biocompatibility studies. J Mater Sci Mater Med 1997; 8; 163-74. (Pubitemid 27116634)
19. Suknuntha K, Tantishaiyakul V, Vao-Soongnern V, Espidel Y, Cosgrove T. Molecular Modeling Simulation and Experimental Measurements to Characterize Chitosan and Poly(vinyl pyrrolidone) Blend Interactions. J Polym Sci B 2008; 46: 1258-64.
20. Demirci S, Alaslan A, Caykara T. Preparation, characterization and surface pKa values of poly(N-vinyl-2-pyrrolidone)/chitosan blend films. Appl Surf Sci 2009; 255: 5979-83.
21. Dergunov SA, Mun GA. irradiated chitosan-polyvinyl pyrrolidone hydrogels as pH-sensitive protein delivery system. Rad Phys Chem 2009; 78: 65-8.
22. Sleevi M. In: Insulin and hypoglycemic agents. Abraham, DJ. Ed.; Burger's Medicinal Chemistry and Drug Discovery, Autocoids, Diagnostics, and Drugs from New Biology. John Wiley & Sons, Inc.: New York 2003.
23. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: Scientific review. JAMA 2002; 287: 360-72. (Pubitemid 34256388)
24. Yale JF. Oral antihyperglycemic agents and renal disease: New agents, new consepts. J Am Soc Nephrol 2005; 16: S7-S10.
25. Kar P, Richard, Holt IG. The effect of sulphonylureas on the microvascular and macrovascular complications of diabetes. Cardiovasc Drugs Ther 2008; 22: 207-13.
26. Jirovsky D, Bartosova Z, Skopalova J, Maier V. Electrochemical characterization of repaglinide and its determination in human plasma using liquid chromatography with dual-channel coulometric detection. J Chrom B 2010; 878(31): 3243-8.
27. Mandic Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal 2006; 41: 866-71.
28. Borde PP, Subbappa PKB, Kodinvaka R. Repaglinide formulations. U.S. Patent, 20,090,209,587 A1. August 20, 2009.
29. http://www.rxlist.com/pradin-drug.htm, (Accessed January 10,2010).
30. Purvis T, Mattucci ME, Crisp MT, Johnston KP, Williams III RO. Rapidly Dissolving Repaglinide Powders Produced by the Ultra- Rapid Freezing Process. AAPS Pharm Sci Tech 2007; 8(3): E1-E9.
31. Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. J Control Release 2005; 107: 300-9. (Pubitemid 41316292)
32. Singh A, Narvi SS, Dutta PK, Pandey ND. External stimuli response on a novel chitosan hydrogel crosslinked with formaldehyde. Bull Mater Sci 2006; 29(3): 233-8. (Pubitemid 44047641)
33. Marsano E, Bianchi E, Vicini S, Compagnino L, Sionkowska A, Skopinska J, Wisniewski M. Stimuli responsive gels based on interpenetrating network of chitosan and poly(vinylpyrrolidone). Polymer 2005; 46: 1595-600. (Pubitemid 40170123)
34. Gupta A, Garg S, Khar RK. Measurement of bioadhesive strength of mucoadhesive buccal tablets: Design of an in vitro assembly. Ind Drugs 1993; 30(4): 152-5. (Pubitemid 23359340)
35. Jivani RR, Patel CN, Jivani NP. Design and Development of a Self Correcting Monolithic Gastroretentive Tablet of Baclofen. Sci Pharm 2009; 77: 651-67.
36. Singh B, Ahuja N Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm 2002; 28: 431-42. (Pubitemid 34552236)
37. Bernkop-Schnurch A Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm 2000; 194: 1-13.
38. Patel RS, Poddar SS. Development and characterization of mucoadhesive buccal patches of salbutamol sulphate. Curr Drug Delevery 2009; 6: 140-4.
39. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev 2005; 57: 1666-91.
40. Karava E, Georgarakis E, Bikiaris D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm 2006; 64: 115-26. (Pubitemid 44160659)
41. Sakkinen M, Marvola J, Kanerva H, Lindevall K, Ahonen A, Marvola M. Are chitosan formulations mucoadhesive in the human small intestine? An evaluation based on gamma scintigraphy. Int J Pharm 2006; 307: 285-91. (Pubitemid 41820426)
42. Shalaby WS, Peck GE, Park K. Release of dextomethophan hydrobromide from freeze-dried enzyme degradable hydrogels. J Control Release 1991; 16: 355-64.
43. Vaghani SS, Patel SG, Jivani RJ, Jivani NP, Patel MM, Borda R. Design and optimization of stomach specific drug delivery system of repaglinide: Application of simplex lattice design. Pharm Dev Technol 2010. [Epub ahead of print].
44. Banerjee T, Mitra S, Singh AK, Sharma RK, Maitra A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 2002; 243: 93-105.
45. Nam SY, Lee YM. Pervaporation and properties of chitosanpoly( acrylic acid) complex membranes. J Membrane Sci 1997; 135: 161-71. (Pubitemid 27494111)
46. Anjali-Devi D, Smitha B, Sridhar B, Aminabhavi TM. Novel crosslinked chitosan/poly(vinylpyrrolidone) blend membranes for dehydrating tetrahydrofuran by the pervaporation technique. J Membrane Sci 2006; 280: 45-63.
47. Neira-Carrillo A, Yazdani-Pedram M, Retuert J, Diaz-Dosque M, Gallois S, Arias JL. Selective crystallization of calcium salts by poly(acrylate)-graphted chitosan. J Colloid Interf Sci 2005; 286: 134-41. (Pubitemid 40569355)
48. Smitha B, Sridhar S, Khan AA. Chitosan-poly(vinyl pyrrolidone) blends as membranes for direct methanol fuel cell applications. J Power Sources 2006; 159: 846-54. (Pubitemid 44301720)
49. Zhao L, Mitomo H, Zhai M, Yoshii F, Nagasawa N, Kume T. Synthesis of antibacterial PVA/CM-chitosan blend hydrogels with electron beam irradiation. Carbohydr Polym 2003; 53: 439-46.
50. Gandhimathi M, Ravi TK, Renu SK. Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection. Anal Sci 2003; 19: 1675-7.
51. Yao J, Shi YQ, Li ZR, Jin SH. Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. J Chrom B 2007; 853: 254-9. (Pubitemid 46891363)
52. Vaghani S, Vasanti S, Chaturvedi K, Satish CS, Shankar SJ. Formulation and Evaluation of 5-FU Loaded Eudragit Microspheres: Effect of Various Eudragit on Micromeretic Properties of Microspheres. J Macromol Sci Chem 2008; 45: 1015-27.
53. Vaghani S, Vasanti S, Chaturvedi K, Satish CS, Jivani NP. Stomach- specific drug delivery of 5-Fluorouracil using ethylcellulose floating microspheres. Pharm Dev Tech 2010; 15(2): 154-61.